General Information of Drug Transporter (DT)
DT ID DTD0158 Transporter Info
Gene Name SLC23A1
Transporter Name Sodium-dependent vitamin C transporter 1
Gene ID
9963
UniProt ID
Q9UHI7
Post-Translational Modification of This DT
Overview of SLC23A1 Modification Sites with Functional and Structural Information
Sequence
PTM type
X-N-glycosylation X-Phosphorylation X-Ubiquitination X: Amino Acid

N-glycosylation

  Asparagine

          2 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC23A1 [1]

Role of PTM

Potential impacts

Modified Residue

Asparagine

Modified Location

138

Experimental Method

Co-Immunoprecipitation

Detailed Description

N-linked Glycosylation at SLC23A1 Asparagine 138 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC23A1 [1]

Role of PTM

Potential impacts

Modified Residue

Asparagine

Modified Location

144

Experimental Method

Co-Immunoprecipitation

Detailed Description

N-linked Glycosylation at SLC23A1 Asparagine 144 has the potential to affect its expression or activity.

Phosphorylation

  Serine

          7 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC23A1 [2]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

20

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC23A1 Serine 20 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC23A1 [3]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

477

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC23A1 Serine 477 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence SLC23A1 [2]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

572

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC23A1 Serine 572 has the potential to affect its expression or activity.

  PTM Phenomenon 4

Have the potential to influence SLC23A1 [2]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

573

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC23A1 Serine 573 has the potential to affect its expression or activity.

  PTM Phenomenon 5

Have the potential to influence SLC23A1 [2]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

574

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC23A1 Serine 574 has the potential to affect its expression or activity.

  PTM Phenomenon 6

Have the potential to influence SLC23A1 [2]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

575

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC23A1 Serine 575 has the potential to affect its expression or activity.

  PTM Phenomenon 7

Have the potential to influence SLC23A1 [2] , [4]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

593

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC23A1 Serine 593 has the potential to affect its expression or activity.

  Threonine

        10 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC23A1 [2]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

15

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC23A1 Threonine 15 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC23A1 [2]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

16

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC23A1 Threonine 16 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence SLC23A1 [2] , [5]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

21

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC23A1 Threonine 21 has the potential to affect its expression or activity.

  PTM Phenomenon 4

Have the potential to influence SLC23A1 [3]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

484

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC23A1 Threonine 484 has the potential to affect its expression or activity.

  PTM Phenomenon 5

Have the potential to influence SLC23A1 [3]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

498

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC23A1 Threonine 498 has the potential to affect its expression or activity.

  PTM Phenomenon 6

Have the potential to influence SLC23A1 [3]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

499

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC23A1 Threonine 499 has the potential to affect its expression or activity.

  PTM Phenomenon 7

Have the potential to influence SLC23A1 [4] , [6]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

585

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC23A1 Threonine 585 has the potential to affect its expression or activity.

  PTM Phenomenon 8

Have the potential to influence SLC23A1 [2]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

589

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC23A1 Threonine 589 has the potential to affect its expression or activity.

  PTM Phenomenon 9

Have the potential to influence SLC23A1 [2]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

591

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC23A1 Threonine 591 has the potential to affect its expression or activity.

  PTM Phenomenon 10

Have the potential to influence SLC23A1 [2]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

596

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC23A1 Threonine 596 has the potential to affect its expression or activity.

Ubiquitination

  Lysine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC23A1 [7]

Role of PTM

Potential impacts

Modified Residue

Lysine

Modified Location

597

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC23A1 Lysine 597 has the potential to affect its expression or activity.

  Unclear Residue

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC23A1 [7]

Role of PTM

Potential impacts

Modified Location

601

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC23A1 601 has the potential to affect its expression or activity.
References
1 Topological studies of hSVCT1, the human sodium-dependent vitamin C transporter and the influence of N-glycosylation on its intracellular targeting. Exp Cell Res. 2009 Aug 1;315(13):2312-21.
2 Identification of Missing Proteins in the Phosphoproteome of Kidney Cancer. J Proteome Res. 2017 Dec 1;16(12):4364-4373.
3 An Augmented Multiple-Protease-Based Human Phosphopeptide Atlas. Cell Rep. 2015 Jun 23;11(11):1834-43.
4 A fast sample processing strategy for large-scale profiling of human urine phosphoproteome by mass spectrometry. Talanta. 2018 Aug 1;185:166-173.
5 Improving depth in phosphoproteomics by using a strong cation exchange-weak anion exchange-reversed phase multidimensional separation approach. Anal Chem. 2011 Sep 15;83(18):7137-43.
6 Phosphoproteomics Profiling of Nonsmall Cell Lung Cancer Cells Treated with a Novel Phosphatase Activator. Proteomics. 2017 Nov;17(22):10.1002/pmic.201700214.
7 Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. Nature. 2021 Jun;594(7862):246-252.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.